100 related articles for article (PubMed ID: 1317668)
1. Large cell carcinoma of the lung with neuroendocrine differentiation. A comparison with large cell "undifferentiated" pulmonary tumors.
Wick MR; Berg LC; Hertz MI
Am J Clin Pathol; 1992 Jun; 97(6):796-805. PubMed ID: 1317668
[TBL] [Abstract][Full Text] [Related]
2. Immunostaining in the diagnosis of pulmonary neuroendocrine carcinomas. An immunohistochemical study with ultrastructural correlations.
Loy TS; Darkow GV; Quesenberry JT
Am J Surg Pathol; 1995 Feb; 19(2):173-82. PubMed ID: 7832277
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine differentiation in poorly differentiated lung carcinomas: a light microscopic and immunohistologic study.
Visscher DW; Zarbo RJ; Trojanowski JQ; Sakr W; Crissman JD
Mod Pathol; 1990 Jul; 3(4):508-12. PubMed ID: 2170973
[TBL] [Abstract][Full Text] [Related]
4. Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology.
Iyoda A; Hiroshima K; Toyozaki T; Haga Y; Fujisawa T; Ohwada H
Cancer; 2001 Jun; 91(11):1992-2000. PubMed ID: 11391577
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary large cell carcinoma expressing neuroendocrine markers: the morphological, biological, and neuroendocrine features of their cell lines and surgical cases.
Kasai K; Kameya T; Kawakubo Y; Sato Y; Wada C; Itoh H
Jpn J Cancer Res; 1992 Sep; 83(9):1002-10. PubMed ID: 1331003
[TBL] [Abstract][Full Text] [Related]
6. Chromogranin A gene expression in non-small cell lung carcinomas.
Abbona G; Papotti M; Viberti L; Macrĭ L; Stella A; Bussolati G
J Pathol; 1998 Oct; 186(2):151-6. PubMed ID: 9924430
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours.
Sundaresan V; Reeve JG; Stenning S; Stewart S; Bleehen NM
Br J Cancer; 1991 Aug; 64(2):333-8. PubMed ID: 1654075
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
[TBL] [Abstract][Full Text] [Related]
9. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines.
Jensen SM; Gazdar AF; Cuttitta F; Russell EK; Linnoila RI
Cancer Res; 1990 Sep; 50(18):6068-74. PubMed ID: 2168288
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural and molecular heterogeneity in non-small cell lung carcinomas: study of 110 cases and review of the literature.
Bombí JA; Martínez A; Ramírez J; Grau JJ; Nadal A; Fernández PL; Palacín A; Cardesa A
Ultrastruct Pathol; 2002; 26(4):211-8. PubMed ID: 12227946
[TBL] [Abstract][Full Text] [Related]
11. Non-small cell lung carcinomas with neuroendocrine features. A light microscopic, immunohistochemical and ultrastructural study of 11 cases.
Mooi WJ; Dewar A; Springall D; Polak JM; Addis BJ
Histopathology; 1988 Sep; 13(3):329-37. PubMed ID: 2973427
[TBL] [Abstract][Full Text] [Related]
12. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
Lyda MH; Weiss LM
Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
[TBL] [Abstract][Full Text] [Related]
13. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
Kasprzak A; Zabel M; Biczysko W
Pol J Pathol; 2007; 58(1):23-33. PubMed ID: 17585539
[TBL] [Abstract][Full Text] [Related]
14. [Detection of neuroendocrine differentiation in NSCLC and its clinical significance].
Ouyang N; Chen G; Ding J
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Feb; 24(2):90-2. PubMed ID: 11802946
[TBL] [Abstract][Full Text] [Related]
15. Amphicrine differentiation in bronchioloalveolar cell carcinoma.
Sheppard MN; Thurlow NP; Dewar A
Ultrastruct Pathol; 1994; 18(4):437-41. PubMed ID: 7941042
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer.
Graziano SL; Tatum AH; Newman NB; Oler A; Kohman LJ; Veit LJ; Gamble GP; Coleman MJ; Barmada S; O'Lear S
Cancer Res; 1994 Jun; 54(11):2908-13. PubMed ID: 8187076
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical and ultrastructural study of mixed small cell/large cell carcinoma of the lung. Expression of Sialyl LeX-i antigens and scarcity of neuroendocrine characteristics.
Yokose T; Asami H; Ito Y
Acta Pathol Jpn; 1991 Jul; 41(7):540-51. PubMed ID: 1661556
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T
Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138
[TBL] [Abstract][Full Text] [Related]
19. Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum.
Grabowski P; Schönfelder J; Ahnert-Hilger G; Foss HD; Heine B; Schindler I; Stein H; Berger G; Zeitz M; Scherübl H
Virchows Arch; 2002 Sep; 441(3):256-63. PubMed ID: 12242522
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary meningioma. Immunohistochemical and ultrastructural features.
Drlicek M; Grisold W; Lorber J; Hackl H; Wuketich S; Jellinger K
Am J Surg Pathol; 1991 May; 15(5):455-9. PubMed ID: 2035740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
